AbbVie Launches New API Manufacturing Facility in Illinois
AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone ...
AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone ...
Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Inluriyo (imlunestrant, 200 mg tablets), an ...
Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, ...
The U.S. Food and Drug Administration (FDA) announced that it will issue approximately 100 cease-and-desist enforcement notices alongside thousands of ...
The U.S. Food and Drug Administration has granted approval to Johnson & Johnson’s drug delivery system for a specific type ...
Eli Lilly and Company has officially introduced the Lilly TuneLab AI platform, a new artificial intelligence and machine learning system ...
Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into ...
Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. ...
NORTH CHICAGO, Ill. and NEW YORK, Aug. 25, 2025 -- AbbVie and Gilgamesh Pharmaceuticals Inc. ("Gilgamesh") announced a definitive agreement ...
Johnson & Johnson, an industry leader known for its global healthcare innovation, unveiled plans to increase its presence in the ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.